<!DOCTYPE html>
<html>
  <script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-79742963-1', 'auto');
  ga('send', 'pageview');

</script>

  <!-- Begin Jekyll SEO tag v2.5.0 -->
<title>Combined immunotherapy is successful in carcinoma caused by papillomavirus 16 | Ciência médica</title>
<meta name="generator" content="Jekyll v3.7.4" />
<meta property="og:title" content="Combined immunotherapy is successful in carcinoma caused by papillomavirus 16" />
<meta name="author" content="ffelix" />
<meta property="og:locale" content="en" />
<meta name="description" content="Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncology, showing that combined treatment with nivolumabe and ISA101 (a papillomavirus 16 vaccine) has effect in patients with advanced disease." />
<meta property="og:description" content="Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncology, showing that combined treatment with nivolumabe and ISA101 (a papillomavirus 16 vaccine) has effect in patients with advanced disease." />
<link rel="canonical" href="http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html" />
<meta property="og:url" content="http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html" />
<meta property="og:site_name" content="Ciência médica" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2018-09-27T18:00:00-03:00" />
<script type="application/ld+json">
{"description":"Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncology, showing that combined treatment with nivolumabe and ISA101 (a papillomavirus 16 vaccine) has effect in patients with advanced disease.","author":{"@type":"Person","name":"ffelix"},"@type":"BlogPosting","url":"http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html","headline":"Combined immunotherapy is successful in carcinoma caused by papillomavirus 16","dateModified":"2018-09-27T18:00:00-03:00","datePublished":"2018-09-27T18:00:00-03:00","mainEntityOfPage":{"@type":"WebPage","@id":"http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html"},"@context":"http://schema.org"}</script>
<!-- End Jekyll SEO tag -->

  <head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <!-- Begin Jekyll SEO tag v2.5.0 -->
<title>Combined immunotherapy is successful in carcinoma caused by papillomavirus 16 | Ciência médica</title>
<meta name="generator" content="Jekyll v3.7.4" />
<meta property="og:title" content="Combined immunotherapy is successful in carcinoma caused by papillomavirus 16" />
<meta name="author" content="ffelix" />
<meta property="og:locale" content="en" />
<meta name="description" content="Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncology, showing that combined treatment with nivolumabe and ISA101 (a papillomavirus 16 vaccine) has effect in patients with advanced disease." />
<meta property="og:description" content="Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncology, showing that combined treatment with nivolumabe and ISA101 (a papillomavirus 16 vaccine) has effect in patients with advanced disease." />
<link rel="canonical" href="http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html" />
<meta property="og:url" content="http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html" />
<meta property="og:site_name" content="Ciência médica" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2018-09-27T18:00:00-03:00" />
<script type="application/ld+json">
{"description":"Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncology, showing that combined treatment with nivolumabe and ISA101 (a papillomavirus 16 vaccine) has effect in patients with advanced disease.","author":{"@type":"Person","name":"ffelix"},"@type":"BlogPosting","url":"http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html","headline":"Combined immunotherapy is successful in carcinoma caused by papillomavirus 16","dateModified":"2018-09-27T18:00:00-03:00","datePublished":"2018-09-27T18:00:00-03:00","mainEntityOfPage":{"@type":"WebPage","@id":"http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html"},"@context":"http://schema.org"}</script>
<!-- End Jekyll SEO tag -->


  <!--
 <link rel="alternate" hreflang="en" href="/ciencia-medica/2018/09/27/combined-immunotherapy.html" />
 <link rel="alternate" hreflang="pt-br" href="/ciencia-medica/2018/09/27/imunoterapia-combinada.html" />
  -->
 <link rel="alternate" type="application/rss+xml" title="" href="/ciencia-medica">

  <title>Combined immunotherapy is successful in carcinoma caused by papillomavirus 16</title>
  <meta name="description" content="Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncolog...">

  <!-- Google Fonts loaded here depending on setting in _data/options.yml true loads font, blank does not-->
  
    <link href='//fonts.googleapis.com/css?family=Lato:400,400italic' rel='stylesheet' type='text/css'>
  

  <!-- Load up MathJax script if needed ... specify in /_data/options.yml file-->
  
    <script type="text/javascript" src="//cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
  

  <link rel="stylesheet" type="text/css" href="/ciencia-medica/css/tufte.css">
  <!-- <link rel="stylesheet" type="text/css" href="/ciencia-medica/css/print.css" media="print"> -->

  <link rel="canonical" href="http://fhcflx.github.io/ciencia-medica/2018/09/27/combined-immunotherapy.html">
  <link rel="icon"
        type="image/png"
        href="/assets/img/badge.png">

  <link rel="alternate" type="application/rss+xml" title="Ciência médica" href="http://fhcflx.github.io/ciencia-medica/feed.xml" />

  <link rel="apple-touch-icon" sizes="180x180" href="/ciencia-medica/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/ciencia-medica/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/ciencia-medica/favicon-16x16.png">
  <link rel="manifest" href="/ciencia-medica/site.webmanifest">
  <link rel="mask-icon" href="/ciencia-medica/safari-pinned-tab.svg" color="#5bbad5">
  <link rel="shortcut icon" href="/ciencia-medica/favicon.ico">
  <meta name="msapplication-TileColor" content="#da532c">
  <meta name="msapplication-config" content="/ciencia-medica/browserconfig.xml">
  <meta name="theme-color" content="#ffffff">

</head>

  <body>
    <!--- Hader and nav template site-wide -->
<header>
    <a class="site-title" href="/ciencia-medica/"></a>
    <nav class="group">
	<a href="/ciencia-medica/"><img class="badge" src="/ciencia-medica/assets/img/mybadge.png" alt="CH"></a>
        
	
		
		    
		      <a href="/ciencia-medica/index.html">Medical Science</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/all-posts/index.html">All</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/vascular/index.html">Vascular anomalies</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/cancer2/index.html">Cancer</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/markers/index.html">Tags</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/about/index.html">About</a>
		    
	    
  	
        <!--<div class="trigger">
            
            
               
               <a class="page-link" href="/ciencia-medica/index.html">Medical Science</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/all-posts/index.html">All</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/vascular/index.html">Vascular anomalies</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/cancer2/index.html">Cancer</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/markers/index.html">Tags</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/about/index.html">About</a>
               
            
            </div>-->
  </nav>
<div class="wrapper" style="text-align: right; line-height: 2em">
  
   <a href="/ciencia-medica/2018/09/27/combined-immunotherapy.html" class="en">en}</a>  <a href="/ciencia-medica/2018/09/27/imunoterapia-combinada.html" class="pt-br">pt-br}</a> 

  
  
</div>
</header>

    <article class="group">
      <h1>Combined immunotherapy is successful in carcinoma caused by papillomavirus 16</h1>
<p class="subtitle">

27
Setembro
  
2018</p>



  <span>
    Escrito por Francisco H. C. Felix
  </span>



<ul class="tags">
  
    <li><a href="/ciencia-medica/marcadores#Cancer" class="tag">Cancer</a></li>
  
    <li><a href="/ciencia-medica/marcadores#Immunotherapy" class="tag">Immunotherapy</a></li>
  
</ul>

<p>Researchers at the MD Anderson Cancer Center have published the results of a Phase II trial in the Journal of the American Medical Association (JAMA) Oncology, showing that combined treatment with nivolumabe and ISA101 (a papillomavirus 16 vaccine) has effect in patients with advanced disease.
<!--more--></p>

<p>Papillomavirus-dependent carcinoma in advanced stage has no established treatment. Trials with the PD-1 inhibitor nivolumabe did not show significant efficacy in these patients. The papillomavirus 16 vaccine, ISA101, has been shown to induce a strong immune response in patients, but has no effect on advanced disease.</p>

<p>Researchers treated 24 patients, 22 with advanced oropharyngeal carcinoma, with nivolumabe EV 3 mg/kg every 2 weeks for 1 year and ISA101 100 micrograms SC on days 1, 22 and 50.</p>

<p>The evaluation showed a response in 33% of patients, median duration of response of 10.3 months and median survival of 17.5 months. Only 2 patients had grade 3-4 toxicity.</p>

<p>The authors concluded that treatment of advanced carcinoma with combined immunotherapy (PD-1 inhibitor and papillomavirus vaccine 16) may be successful and larger trials should be planned to test this association.</p>

<p><em>This post does not represent a suggestion for treatment. Only a specialist can judiciously decide what information disclosed can modify a treatment scheme in any way, and in what form.</em></p>

<p>The study can be read <a href="http://bit.ly/fhcflxXt">here</a>.</p>



<article style="max-width: 90%;">
  <div id="disqus_thread"></div>
  <script>
    /**
     *  RECOMMENDED CONFIGURATION VARIABLES: EDIT AND UNCOMMENT THE SECTION BELOW TO INSERT DYNAMIC VALUES FROM YOUR PLATFORM OR CMS.
     *  LEARN WHY DEFINING THESE VARIABLES IS IMPORTANT: https://disqus.com/admin/universalcode/#configuration-variables
     */
    /*
    var disqus_config = function () {
        this.page.url = PAGE_URL;  // Replace PAGE_URL with your page's canonical URL variable
        this.page.identifier = PAGE_IDENTIFIER; // Replace PAGE_IDENTIFIER with your page's unique identifier variable
    };
    */
      (function() {  // DON'T EDIT BELOW THIS LINE
          var d = document, s = d.createElement('script');
              s.src = '//pharmak-on.disqus.com/embed.js';

            s.setAttribute('data-timestamp', +new Date());
            (d.head || d.body).appendChild(s);
        })();
  </script>
  <noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript" rel="nofollow">comments powered by Disqus.</a></noscript>
</article>


    </article>
    <span class="print-footer">Combined immunotherapy is successful in carcinoma caused by papillomavirus 16 - September 27, 2018 - fhcflx</span>
    <footer>
  <hr class="slender">
  <ul class="footer-links">
    <li><a href="mailto:fhcflx@outlook.com"><span class="icon-mail"></span></a></li>
    
      <li>
        <a href="//www.twitter.com/fhcflx"><span class="icon-twitter"></span></a>
      </li>
    
      <li>
        <a href="//plus.google.com/+FranciscoHCFelix"><span class="icon-googleplus"></span></a>
      </li>
    
      <li>
        <a href="//github.com/fhcflx/ciencia-medica"><span class="icon-github"></span></a>
      </li>
    
      <li>
        <a href="//www.flickr.com/photos/fhcflx"><span class="icon-flickr"></span></a>
      </li>
    
      <li>
        <a href=""><span class="icon-feed"></span></a>
      </li>
    
    <li><a href=https://travis-ci.org/fhcflx/ciencia-medica ><img alt='travis-ci build' src=https://img.shields.io/travis/fhcflx/ciencia-medica.svg?colorA=a00000&colorB=a00000></a></li>
  </ul>
<div class="credits">
<span>&copy; 2019 &nbsp;&nbsp;FHCFLX</span></br> <br>
<span>Este sítio foi criado com o <a href="//github.com/clayh53/tufte-jekyll">tema Tufte para Ciência médica </a> no <a href="//jekyllrb.com">Jekyll</a>.</span>
</div>
</footer>

  </body>
</html>
